A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
NCT00545363
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
716
Enrollment
INDUSTRY
Sponsor class
Conditions
Postmenopausal Osteoporosis
Interventions
DRUG:
Ibandronate
Sponsor
Hoffmann-La Roche